While the T2DM subjects in our study had higher HbA1c levels compared to controls, the mean HbA1c result was much lower than that reported previously [50], possibly suggesting a lack of change in LCAT activity may be due to better glycaemic control. The gene discussed is LCAT; the disease is type 2 diabetes mellitus.